Physician profile
Jonah A Schey
NPI 1609215904
$474.54
in general payments reported to CMS, 2019-2025
9 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.00 · 2021: $51.63 · 2022: $16.72 · 2023: $47.03 · 2024: $175 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $116.62 | 2020-2025 | Bexsero, Rotarix |
| Seqirus USA INC | $89.50 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $87.95 | 2021-2025 | |
| Mirum Pharmaceuticals, INC. | $61.31 | 2024-2025 | Cholbam, Cholbam |
| Merck Sharp & Dohme LLC | $36.39 | 2021-2025 | Gardasil 9, Enflonsia |
| Collegium Pharmaceutical, INC. | $35.44 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $17.06 | 2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $15.46 | 2021 | |
| Cranial Technologies, INC | $14.81 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonah Schey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.